TGTX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

TG Therapeutics Inc

NASDAQ | TGTX

33.26

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$5.30B

Market Cap

12.06

P/E Ratio

2.77

EPS

$46.48

52 Week High

$25.28

52 Week Low

HEALTHCARE

Sector

TGTX Chart

Recent Chart
Price Action

TGTX Technicals

Tags:

TGTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $291M
Total Revenue $329M
Cost Of Revenue $38M
Costof Goods And Services Sold $38M
Operating Income $42M
Selling General And Administrative $154M
Research And Development $94M
Operating Expenses $249M
Investment Income Net -
Net Interest Income -$24M
Interest Income -
Interest Expense $24M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $280K
Income Before Tax $26M
Income Tax Expense $2.2M
Interest And Debt Expense -
Net Income From Continuing Operations $23M
Comprehensive Income Net Of Tax -
Ebit $50M
Ebitda $50M
Net Income $23M

Revenue & Profitability

Earnings Performance

TGTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $578M
Total Current Assets $566M
Cash And Cash Equivalents At Carrying Value $180M
Cash And Short Term Investments $180M
Inventory $110M
Current Net Receivables $129M
Total Non Current Assets $11M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill $799K
Investments -
Long Term Investments $808K
Short Term Investments $131M
Other Current Assets $16M
Other Non Current Assets -
Total Liabilities $355M
Total Current Liabilities $91M
Current Accounts Payable $58M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $265M
Capital Lease Obligations $9.3M
Long Term Debt $244M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $254M
Other Current Liabilities $78M
Other Non Current Liabilities -
Total Shareholder Equity $222M
Treasury Stock -
Retained Earnings -$1.5B
Common Stock $156K
Common Stock Shares Outstanding $160M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$41M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $280K
Capital Expenditures $45K
Change In Receivables -
Change In Inventory -$67M
Profit Loss -
Cashflow From Investment -$1M
Cashflow From Financing $129M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$8.8M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $23M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $291M
Total Revenue $329M
Cost Of Revenue $38M
Costof Goods And Services Sold $38M
Operating Income $42M
Selling General And Administrative $154M
Research And Development $94M
Operating Expenses $249M
Investment Income Net -
Net Interest Income -$24M
Interest Income -
Interest Expense $24M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $280K
Income Before Tax $26M
Income Tax Expense $2.2M
Interest And Debt Expense -
Net Income From Continuing Operations $23M
Comprehensive Income Net Of Tax -
Ebit $50M
Ebitda $50M
Net Income $23M

TGTX News

TGTX Profile

TG Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

TG Therapeutics, Inc. (TGTX) is a prominent biopharmaceutical company based in New York, specializing in the development and commercialization of targeted therapies for B-cell malignancies and autoimmune diseases. With a robust pipeline of innovative product candidates, the company leverages advanced drug development technologies, positioning itself as a leader in the oncology and autoimmune treatment landscape. Committed to addressing significant unmet medical needs, TG Therapeutics focuses on enhancing patient outcomes through its precision medicine strategies and extensive clinical development programs.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+19.82%
$0.47
TLRY
-22.27%
$0.80
IPG
-1.95%
$24.57
BITF
+10.80%
$3.43
INTC
+9.08%
$40.15
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
BMNR
+4.53%
$33.18
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
RUBI
-26.31%
$0.15
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
INHD
-0.97%
$0.22
PLUG
+2.27%
$2.02
BIYA
+10.67%
$0.27
SRM
+53.27%
$10.30
CHR
-2.55%
$0.04
ONMD
+31.69%
$1.87
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
GPUS
-8.58%
$0.30
AAL
+0.72%
$14.03
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
ONDS
-4.36%
$7.88
SOFI
+4.31%
$29.72
NIO
+1.09%
$5.51
ADTX
+21.01%
$3.80
F
+0.61%
$13.27
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
BURU
+7.72%
$0.22
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
GOOGL
-0.26%
$319.09
PFE
0.00%
$25.71
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
CRCL
+9.28%
$79.38
BTG
+3.25%
$4.61
AIIO
-9.09%
$0.70
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
BAC
+1.28%
$53.67
AMCR
+1.29%
$8.62
AMD
+1.53%
$217.53
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
RIOT
+6.97%
$16.00
IREN
-1.31%
$47.81
AG
+12.47%
$15.19
NGD
+5.92%
$8.30
AGNC
-0.66%
$10.49
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
VEEE
+50.56%
$2.68
YCBD
-3.44%
$0.53
NVO
+1.21%
$49.30
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
GOOG
-0.34%
$319.17
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
RIVN
+4.82%
$16.96
ZAPP
-46.30%
$0.15
MSFT
+1.34%
$492.01
CDE
+6.08%
$17.17
SMR
+4.38%
$19.87
SNDK
+3.83%
$223.28
HOOD
+0.22%
$128.49
MSTR
+0.01%
$175.66
BTE
+2.84%
$3.25
ITUB
+2.02%
$7.81
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+51.88%
$1.61
VINE
+10.76%
$0.39
NVDA
-1.80%
$177.00
AMZE
+19.82%
$0.47
TLRY
-22.27%
$0.80
IPG
-1.95%
$24.57
BITF
+10.80%
$3.43
INTC
+9.08%
$40.15
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
TSLA
+1.71%
$426.58
BYND
-4.59%
$0.97
BMNR
+4.53%
$33.18
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
RUBI
-26.31%
$0.15
CLSK
+11.97%
$15.06
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
INHD
-0.97%
$0.22
PLUG
+2.27%
$2.02
BIYA
+10.67%
$0.27
SRM
+53.27%
$10.30
CHR
-2.55%
$0.04
ONMD
+31.69%
$1.87
SNAP
+0.37%
$7.63
WULF
+4.51%
$15.51
TWOH
0.00%
$0.00
BMNU
+3.72%
$7.79
CIFR
+7.41%
$20.56
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
GPUS
-8.58%
$0.30
AAL
+0.72%
$14.03
MARA
+4.18%
$11.57
VALE
+0.79%
$12.61
ONDS
-4.36%
$7.88
SOFI
+4.31%
$29.72
NIO
+1.09%
$5.51
ADTX
+21.01%
$3.80
F
+0.61%
$13.27
AFMD
-34.94%
$0.18
DEFT
+9.24%
$1.51
BURU
+7.72%
$0.22
APLD
+5.05%
$24.94
BTBT
+1.15%
$2.34
KWM
+17.30%
$0.77
GOOGL
-0.26%
$319.09
PFE
0.00%
$25.71
SMX
+244.97%
$60.02
AMZN
+1.77%
$233.22
CRCL
+9.28%
$79.38
BTG
+3.25%
$4.61
AIIO
-9.09%
$0.70
GRYP
-10.38%
$1.38
DVLT
-7.05%
$1.97
HBI
-2.20%
$6.44
ACHR
+4.79%
$7.84
MODV
-25.22%
$0.43
BAC
+1.28%
$53.67
AMCR
+1.29%
$8.62
AMD
+1.53%
$217.53
IBRX
+9.15%
$2.32
CAN
+10.07%
$1.01
GRAB
+2.34%
$5.44
RIOT
+6.97%
$16.00
IREN
-1.31%
$47.81
AG
+12.47%
$15.19
NGD
+5.92%
$8.30
AGNC
-0.66%
$10.49
KDLY
+7.20%
$0.49
DNN
+0.39%
$2.57
VEEE
+50.56%
$2.68
YCBD
-3.44%
$0.53
NVO
+1.21%
$49.30
CRCA
+17.43%
$4.32
AMC
+5.99%
$2.43
TMC
+17.92%
$6.87
GOOG
-0.34%
$319.17
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
RIG
+1.97%
$4.38
CRWV
-1.57%
$73.12
SHOT
-74.37%
$0.39
RIVN
+4.82%
$16.96
ZAPP
-46.30%
$0.15
MSFT
+1.34%
$492.01
CDE
+6.08%
$17.17
SMR
+4.38%
$19.87
SNDK
+3.83%
$223.28
HOOD
+0.22%
$128.49
MSTR
+0.01%
$175.66
BTE
+2.84%
$3.25
ITUB
+2.02%
$7.81
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.